{"meta":{"query_hash":"19e020684579","filters":{"venue":"Resistance to targeted anti-cancer therapeutics"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/19e020684579","api":"https://metacan.xera.ac/api/v1/cohort?venue=Resistance+to+targeted+anti-cancer+therapeutics"},"results":[{"id":"W2794943680","doi":"10.1007/978-3-319-67932-7_9","title":"Resistance to Inhibitors of Angiogenesis","year":2018,"lang":"en","type":"book-chapter","venue":"Resistance to targeted anti-cancer therapeutics","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Angiogenesis; Stromal cell; Cancer research; Blockade; Downregulation and upregulation; Metastasis; Vascular endothelial growth factor; Medicine; Tumor progression; Biology; Cancer; Receptor; VEGF receptors; Internal medicine","score_opus":0.021747234990770494,"score_gpt":0.2760519939831697,"score_spread":0.25430475899239924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794943680","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06303603,0.40607777,0.022964345,0.011447054,0.0024263742,0.00024063786,0.00078153744,0.00078449235,0.49224183],"genre_scores_gemma":[0.3365895,0.2541059,0.0070656715,0.0062866225,0.00121376,0.00032007697,0.0011191079,0.00020141072,0.393098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998118,0.000029745182,0.000008166402,0.000036901525,0.000082599974,0.000030707604],"domain_scores_gemma":[0.99991846,0.00002964419,0.000016629076,0.000008897855,0.000015647844,0.000010634177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023677021,0.0005166193,0.00033386168,0.00058772136,0.00018249133,0.0008457945,0.00028751258,0.0005351857,0.005585654],"category_scores_gemma":[0.00032993688,0.00018026728,0.00026076136,0.00036218655,0.0003239086,0.0005123961,0.00037208482,0.0014866252,0.0024103925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002566549,0.00031510193,0.0007086323,0.0008551402,0.00005403807,0.0007802285,0.00019710624,0.0019248218,0.18762147,0.08630195,0.07778095,0.6432039],"study_design_scores_gemma":[0.000041337065,0.0003399155,0.00071951124,0.00016985623,0.00002662279,0.0036967748,0.000025661411,0.0009414556,0.062183574,0.007835131,0.9240035,0.00001673555],"about_ca_topic_score_codex":0.000296301,"about_ca_topic_score_gemma":0.000384866,"teacher_disagreement_score":0.005585654,"about_ca_system_score_codex":0.00055983925,"about_ca_system_score_gemma":0.00026794637,"threshold_uncertainty_score":0.018685818},"labels":[],"label_agreement":null},{"id":"W2958061269","doi":"10.1007/978-3-030-21477-7_10","title":"Nanomedicine and Drug Delivery Systems in Overcoming Resistance to Targeted Therapy","year":2019,"lang":"en","type":"book-chapter","venue":"Resistance to targeted anti-cancer therapeutics","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Military College of Canada","funders":"","keywords":"Nanomedicine; Nanocarriers; Drug delivery; Targeted drug delivery; Drug; Medicine; Nanotechnology; Drug resistance; Pharmacology; Biology; Materials science","score_opus":0.021624248084960874,"score_gpt":0.252995042158602,"score_spread":0.23137079407364114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958061269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052102986,0.73624337,0.03619426,0.003920578,0.003549476,0.00013026591,0.00016027076,0.00029221468,0.21429929],"genre_scores_gemma":[0.035614848,0.5433027,0.035795238,0.003551338,0.0017650065,0.00030245012,0.00020246235,0.0002188994,0.37924707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985266,0.00003152173,0.000005996169,0.000028934268,0.000067125504,0.000013821715],"domain_scores_gemma":[0.9999342,0.000041783027,0.000005674436,0.0000033548881,0.00001119236,0.0000037407997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003653839,0.00069479167,0.00055148616,0.00084371696,0.0003516511,0.0011375037,0.000590983,0.0011440493,0.008221093],"category_scores_gemma":[0.00023957352,0.0003273486,0.0002556981,0.0007081716,0.0006633979,0.0017683905,0.0007191251,0.0014578647,0.004440723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012987677,0.00021945663,0.00007293852,0.0035679452,0.000029272493,0.00036402149,0.00038775094,0.003236035,0.08363915,0.20279478,0.07943298,0.6261259],"study_design_scores_gemma":[0.000010350489,0.00009198996,0.00009753425,0.0003025465,0.000012573398,0.0004968249,0.000050136183,0.0015227806,0.016230201,0.021164205,0.9600053,0.000015598425],"about_ca_topic_score_codex":0.00043390854,"about_ca_topic_score_gemma":0.0009302275,"teacher_disagreement_score":0.008221093,"about_ca_system_score_codex":0.00070582615,"about_ca_system_score_gemma":0.00043322597,"threshold_uncertainty_score":0.027502298},"labels":[],"label_agreement":null},{"id":"W2958585199","doi":"10.1007/978-3-030-21477-7_2","title":"Targeting the Tumor Microenvironment to Overcome Resistance to Therapy","year":2019,"lang":"en","type":"book-chapter","venue":"Resistance to targeted anti-cancer therapeutics","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Tumor microenvironment; Carcinogenesis; Cancer research; Cancer; Receptor tyrosine kinase; Biology; Tumor progression; Cancer cell; Immunology; Signal transduction; Cell biology; Tumor cells","score_opus":0.01998299850713228,"score_gpt":0.2505592253411579,"score_spread":0.2305762268340256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958585199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014573322,0.48410377,0.050220657,0.010144428,0.004448068,0.0001293309,0.00029574084,0.0006764116,0.43540823],"genre_scores_gemma":[0.083733276,0.37371886,0.0219328,0.0055264845,0.0017249038,0.00019920575,0.00023497056,0.00020345842,0.51272595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999399,0.000007746217,0.0000015698542,0.000010157886,0.000032216096,0.000008435105],"domain_scores_gemma":[0.9999751,0.000012262485,0.000002418231,0.0000020621394,0.0000046993487,0.000003502462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001396012,0.00032913763,0.00035308936,0.00041054573,0.00014430952,0.0010415307,0.00038511175,0.000534802,0.008359265],"category_scores_gemma":[0.0001027773,0.00015705512,0.0001618017,0.00029603444,0.00037643398,0.00080323813,0.00045977486,0.0014436019,0.004022759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008837187,0.00019892416,0.0001642658,0.000947831,0.000018874856,0.00028695774,0.00021528592,0.0021211656,0.19598582,0.11843412,0.09835642,0.5831819],"study_design_scores_gemma":[0.000012068435,0.00006295206,0.00018449058,0.00014221063,0.00000785792,0.00062966713,0.000042681255,0.00091627176,0.018540215,0.011902394,0.9675522,0.000006884353],"about_ca_topic_score_codex":0.00025279747,"about_ca_topic_score_gemma":0.0006227342,"teacher_disagreement_score":0.008359265,"about_ca_system_score_codex":0.000397148,"about_ca_system_score_gemma":0.0002627451,"threshold_uncertainty_score":0.027964473},"labels":[],"label_agreement":null},{"id":"W2961941726","doi":"10.1007/978-3-030-21477-7_1","title":"Introduction to the Acquisition of Resistance to Targeted Therapy","year":2019,"lang":"en","type":"book-chapter","venue":"Resistance to targeted anti-cancer therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Epigenome; Medicine; Targeted therapy; Cancer; Bioinformatics; Biology; Internal medicine","score_opus":0.014824912475562672,"score_gpt":0.2567423174698578,"score_spread":0.24191740499429515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961941726","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018243338,0.3747756,0.025389263,0.008846929,0.009785316,0.00013852149,0.00090508,0.0005961074,0.5777388],"genre_scores_gemma":[0.008595335,0.21582906,0.010354974,0.0050082556,0.0023612098,0.0001340156,0.00045955987,0.0001884331,0.7570691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998635,0.000015323738,0.000006982451,0.000027898177,0.00007193947,0.0000142564295],"domain_scores_gemma":[0.9998909,0.00005636623,0.000006168281,0.000008121765,0.000027764374,0.000010616789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023766904,0.00061814516,0.00051150867,0.0008628503,0.00030422118,0.0012441184,0.00065954577,0.0010485052,0.03303994],"category_scores_gemma":[0.00031897362,0.000318656,0.00035157937,0.0008251137,0.0005963655,0.001274716,0.0007720922,0.002463061,0.017804598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007417635,0.000109965426,0.000082477876,0.0011796877,0.000010546934,0.00036287258,0.00017637433,0.00096355315,0.012108666,0.11036512,0.3506651,0.5239016],"study_design_scores_gemma":[0.0000020135321,0.000013425488,0.00006268409,0.00010014778,0.0000016213384,0.00032112026,0.000008093405,0.000072470364,0.0006660372,0.0069983867,0.9917503,0.0000038050418],"about_ca_topic_score_codex":0.000670982,"about_ca_topic_score_gemma":0.0010950138,"teacher_disagreement_score":0.03303994,"about_ca_system_score_codex":0.00081460684,"about_ca_system_score_gemma":0.0005262483,"threshold_uncertainty_score":0.11052954},"labels":[],"label_agreement":null},{"id":"W4249754003","doi":"10.1007/978-3-030-21477-7","title":"Current Applications for Overcoming Resistance to Targeted Therapies","year":2019,"lang":"en","type":"book","venue":"Resistance to targeted anti-cancer therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Resistance (ecology); Current (fluid); Biology; Engineering; Electrical engineering","score_opus":0.021567297709106772,"score_gpt":0.2986367846550006,"score_spread":0.27706948694589384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249754003","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011322225,0.8208026,0.012113068,0.0070132976,0.004423613,0.00006362923,0.00014281996,0.0002798029,0.15402885],"genre_scores_gemma":[0.009444546,0.7759588,0.01158041,0.004979129,0.003017635,0.00017165851,0.00030296305,0.00014683964,0.194398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997099,0.00004548859,0.000015748918,0.000044242955,0.00015489153,0.000029645274],"domain_scores_gemma":[0.99979514,0.000106997526,0.000013219204,0.000018046123,0.00004425673,0.000022435215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008508376,0.0010581228,0.0009821426,0.0013364403,0.0003695967,0.0024898103,0.001149772,0.0013529062,0.025305225],"category_scores_gemma":[0.00054681516,0.00039322584,0.00056090695,0.001344968,0.0010724105,0.002884546,0.00091071136,0.003260405,0.012457048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015509813,0.00015064399,0.00007608798,0.0026614843,0.000023003731,0.000203681,0.00015447312,0.0007920323,0.021857928,0.084249794,0.15656444,0.73311126],"study_design_scores_gemma":[0.00001229506,0.00004296197,0.00006231341,0.00022990677,0.000008079115,0.0002836166,0.000020793344,0.00019160195,0.001147612,0.009184653,0.9888103,0.0000058163937],"about_ca_topic_score_codex":0.0003724491,"about_ca_topic_score_gemma":0.000818752,"teacher_disagreement_score":0.025305225,"about_ca_system_score_codex":0.0010068095,"about_ca_system_score_gemma":0.0004904395,"threshold_uncertainty_score":0.08465439},"labels":[],"label_agreement":null}]}